In fiscal year 2022, Dr. Reddy's Laboratories Limited generated the most revenue from its North American market valued at about 75 billion Indian rupees, indicating an increase over the previous year. The company's revenue from the emerging markets which included Russia, other Commonwealth of Independent States countries, Romania and Rest of the World markets was second in place with regard to revenue generation with about 46 billion Indian rupees.
Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region
(in billion Indian rupees)
*Emerging markets include Russia, other Commonwealth of Independent States countries, Romania and Rest of the World markets
**Europe includes Germany, the UK and out-licensing sales business, Italy, France and Spain.
Note: CIS countries refers to the Commonwealth of Independent States that include Azerbaijan, Armenia, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine.
One Indian rupee is equal to 0.012 euros and 0.013 U.S. dollars (as of July 2022).
Values have been rounded.
India's fiscal year starts in April and ends in March. For example, FY 2021 started in April 2020 and ended in March 2021.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Dr. Reddy's Laboratories. (May 19, 2022). Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees) [Graph]. In Statista. Retrieved November 05, 2024, from https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories. "Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees)." Chart. May 19, 2022. Statista. Accessed November 05, 2024. https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories. (2022). Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees). Statista. Statista Inc.. Accessed: November 05, 2024. https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories. "Revenue from Global Generic Drugs of Dr. Reddy's Laboratories Limited in Financial Year 2022, by Region (in Billion Indian Rupees)." Statista, Statista Inc., 19 May 2022, https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
Dr. Reddy's Laboratories, Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees) Statista, https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/ (last visited November 05, 2024)
Revenue from global generic drugs of Dr. Reddy's Laboratories Limited in financial year 2022, by region (in billion Indian rupees) [Graph], Dr. Reddy's Laboratories, May 19, 2022. [Online]. Available: https://www.statista.com/statistics/990990/india-drreddy-s-laboratories-revenue-by-region/
